NASDAQ: DYAI - Dyadic International, Inc.

Lønnsomhet i seks måneder: +35.17%
Sektor: Healthcare

Kampanjeplan Dyadic International, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. It utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus-like particles, protein antigens, ferritin nanoparticles, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins.

flere detaljer
The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to demonstrate the safety in humans of a protein produced from C1-cell protein production platform. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; and strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U., as well as co-development and marketing agreement with Fermbox Bio Inc to design, Develop, and commercialize animal free alternative proteins and biomaterials The company was founded in 1979 and is headquartered in Jupiter, Florida.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

EBITDA -0.0092
EV/EBITDA -14.52
IPO date 2004-11-05
ISIN US26745T1016
Industry Biotechnology
P/BV 3.87
P/S 82.57
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0017
Сайт https://www.dyadic.com
Цена ао 1.58
Число акций ао 0.0288 млрд
Prisendring per dag: +10.73% (1.77)
Prisendring per uke: +12% (1.75)
Prisendring per måned: +4.81% (1.87)
Prisendring over 3 måneder: +78.18% (1.1)
Prisendring over seks måneder: +35.17% (1.45)
Prisendring per år: +21.74% (1.61)
Prisendring over 3 år: -56.25% (4.48)
Prisendring over 5 år: -68.49% (6.22)
Prisendring over 10 år: 0% (1.96)
Prisendring siden begynnelsen av året: +31.54% (1.49)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 15.6 1
P/BV 7.69 1
P/E 0 0
EV/EBITDA -4.74 0
Total: 3.5

Effektivitet

Navn Betydning Karakter
ROA, % -82.68 0
ROE, % -115.6 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0167 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 70.52 8
Lønnsomhet Ebitda, % -10.55 0
Lønnsomhet EPS, % -23.31 0
Total: 2.2
Flere detaljer

Institusjoner Volum Dele, %
Bandera Partners LLC 1566908 5.87
Chapin Davis, Inc. 826301 3.09
Vanguard Group Inc 803917 3.01
Northeast Financial Consultants Inc 250000 0.94
Blackrock Inc. 248614 0.93
Geode Capital Management, LLC 222696 0.83
Sage Mountain Advisors, LLC 106564 0.4
Northern Trust Corporation 77115 0.29
State Street Corporation 56550 0.21
Susquehanna International Group, LLP 48626 0.18

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.00722 13.79 1.54048



Veileder Stillingstittel Betaling Fødselsår
Mr. Mark A. Emalfarb Founder, CEO, President & Director 874.37k 1956 (69 år)
Ms. Ping Wang Rawson CPA, M.B.A. Chief Financial Officer 348.42k 1976 (49 år)
Mr. Joseph P. Hazelton Chief Operating Officer 358.12k 1976 (49 år)
Mr. Doug Pace B.A. Executive Vice President of Business Development N/A
Ms. Ana Gómez Rodriguez Secretary of the Board N/A

Adresse: United States, Jupiter. FL -, 1044 North U.S. Highway One - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.dyadic.com